AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $4,000 | -20.0% | 196 | +18.1% | 0.00% | – |
Q1 2022 | $5,000 | – | 166 | +1975.0% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 8 | -75.0% | 0.00% | – |
Q3 2021 | $1,000 | -97.0% | 32 | -94.7% | 0.00% | – |
Q2 2021 | $33,000 | -62.9% | 603 | -65.1% | 0.00% | -100.0% |
Q1 2021 | $89,000 | +48.3% | 1,728 | +25.1% | 0.00% | 0.0% |
Q4 2020 | $60,000 | +22.4% | 1,381 | -1.4% | 0.00% | 0.0% |
Q3 2020 | $49,000 | -34.7% | 1,401 | +4.2% | 0.00% | 0.0% |
Q2 2020 | $75,000 | – | 1,344 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |